Noninvasive anatomical assessment for ruling out hemodynamically relevant coronary artery anomalies in adults – A comparison of coronary-CT to invasive coronary angiography: The NARCO study design
The NARCO trial will help to optimize AAOCA patient selection for revascularization by improving risk stratification and ruling out hemodynamic relevance noninvasively and, therefore, preventing unnecessary downstream testing and/or costly interventions in patients with AAOCA.
Authors
- Isaac Shiri (ORCID: https://orcid.org/0000-0002-5735-0736)
- Dominik Obrist (ORCID: https://orcid.org/0000-0002-6062-9076)
- Christoph Gräni (ORCID: https://orcid.org/0000-0001-6029-0597)
- Ronny R. Buechel (ORCID: https://orcid.org/0000-0001-8064-8904)
- Anselm W. Stark (ORCID: https://orcid.org/0000-0002-5861-3753)
- Andreas Haeberlin (ORCID: https://orcid.org/0000-0002-9283-0110)
- Federico Caobelli (ORCID: https://orcid.org/0000-0003-2472-775X)
- Andreas A. Giannopoulos (ORCID: https://orcid.org/0000-0002-0938-3170)
- Matthias Siepe (ORCID: https://orcid.org/0000-0003-3305-9343)
- Marius Reto Bigler (ORCID: https://orcid.org/0000-0002-3199-4664)
- Joël Illi
- Lorenz Räber
Institutions
- University of Bern (CH)
- Bern University of Applied Sciences (CH)
- University Hospital of Bern (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.conctc.2024.101394
- Citations
- 6
- Primary Topic
- Coronary Artery Anomalies
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- National Science Foundation
- Novartis Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Schweizerische Herzstiftung